Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Adaptive Biotechnologies Corp (ADPT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/17/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/11/2021 |
4/A
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 3,895 shares
@ $35.43, valued at
$138k
Sold 3,048 shares
@ $35.51, valued at
$108.2k
Sold 847 shares
@ $36.38, valued at
$30.8k
Exercised 3,895 options to buy
@ $6.32, valued at
$24.6k
Exercised 3,895 options to buy
@ $6.32, valued at
$24.6k
|
|
| 03/10/2021 |
4/A
| Pellini Michael J (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 20,000 shares
@ $57.8, valued at
$1.2M
Exercised 20,000 options to buy
@ $6.55, valued at
$131k
|
|
| 01/25/2021 |
4/A
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 31,146 shares
@ $67.02, valued at
$2.1M
Sold 3,001 shares
@ $67.74, valued at
$203.3k
Sold 5,701 shares
@ $69.26, valued at
$394.9k
Sold 8,052 shares
@ $69.97, valued at
$563.4k
Sold 2,100 shares
@ $70.75, valued at
$148.6k
Sold 20,394 shares
@ $66.84, valued at
$1.4M
Sold 24,945 shares
@ $67.39, valued at
$1.7M
Sold 4,661 shares
@ $68.2, valued at
$317.9k
Exercised 50,000 options to buy
@ $6.55, valued at
$327.5k
Exercised 50,000 options to buy
@ $6.55, valued at
$327.5k
|
|
| 05/12/2020 |
4/A
| Cohen Chad M (CFO) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 9,700 shares
@ $24.14, valued at
$234.2k
Sold 5,300 shares
@ $25.07, valued at
$132.9k
Exercised 10,000 options to buy
@ $4.07, valued at
$40.7k
Exercised 5,000 options to buy
@ $6.32, valued at
$31.6k
|
|
| 05/12/2020 |
4/A
| Cohen Chad M (CFO) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 10,000 shares
@ $30, valued at
$300k
Exercised 5,000 options to buy
@ $4.07, valued at
$20.4k
Exercised 5,000 options to buy
@ $6.32, valued at
$31.6k
|
|
| 02/18/2020 |
4/A
| Taylor Stacy L (SVP and General Counsel) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 662 shares
@ $30, valued at
$19.9k
Exercised 662 options to buy
@ $6.55, valued at
$4.3k
|
|
| 01/07/2020 |
4/A
| DOBMEIER ERIC (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 5,000 shares
@ $30, valued at
$150k
Exercised 5,000 options to buy
@ $6.32, valued at
$31.6k
|
|
| 01/07/2020 |
4/A
| DOBMEIER ERIC (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 14,998 shares
@ $29.29, valued at
$439.3k
Sold 2 shares
@ $29.91, valued at
$59.8
Exercised 15,000 options to buy
@ $6.32, valued at
$94.8k
|
|
|
|